Enfuego Therapeutics, Inc.

Funding and NIH signals

• NIH award NIH awarded $312K (SBIR Phase II 1R44CA314597-01, new, notice Sep 14, 2026). NIH RePORTER 1R44CA314597-01 (Sep 14, 2026)
  Evidence (1 event)

  • Sep 14, 2026 · NIH RePORTER 1R44CA314597-01
    Organization: ENFUEGO THERAPEUTICS INC.; City/State: PITTSBORO, NC; Project number: 1R44CA314597-01; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-09-14; FY total cost (award amount): 311734; Administering IC: National Cancer Institute; Project title: Overcoming Adaptive KRAS Inhibitor Resistance with Ligand-Directed KRAS G12V-panTEAD Chimeras; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals